The effect of methionine on the progression of hepatocellular carcinoma induced by ethionine

Z. Brada, N. H. Altman, M. Hill, S. Bulba

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Female Wistar rats were fed a semisynthetic diet containing 0.3% DL-ethionine for 52 weeks and, most of them bearing hepatocellular carcinomas, were switched to a basal diet for one week and then received 80 mg DL-methionine per rat (cir. 25 mg/100 g body wt) by gavage once per day, five times a week, over a period of 13 weeks. Methionine treatment significantly affected progression of hepatic tumors induced by DL-ethionine administration. The frequency of rats with hepatocellular carcinomas in the methionine treated group was significantly lower than that in control groups. It therefore appears that methionine treatment resulted in a remission of the malignant process.

Original languageEnglish
Pages (from-to)157-160
Number of pages4
JournalResearch Communications in Chemical Pathology and Pharmacology
Volume38
Issue number1
StatePublished - Jan 1 1982
Externally publishedYes

Fingerprint

Ethionine
Methionine
Hepatocellular Carcinoma
Rats
Nutrition
Bearings (structural)
Diet
Wistar Rats
Tumors
Control Groups
Liver
Neoplasms

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

The effect of methionine on the progression of hepatocellular carcinoma induced by ethionine. / Brada, Z.; Altman, N. H.; Hill, M.; Bulba, S.

In: Research Communications in Chemical Pathology and Pharmacology, Vol. 38, No. 1, 01.01.1982, p. 157-160.

Research output: Contribution to journalArticle

@article{f6ef97065036487f82672024b2ded0a0,
title = "The effect of methionine on the progression of hepatocellular carcinoma induced by ethionine",
abstract = "Female Wistar rats were fed a semisynthetic diet containing 0.3{\%} DL-ethionine for 52 weeks and, most of them bearing hepatocellular carcinomas, were switched to a basal diet for one week and then received 80 mg DL-methionine per rat (cir. 25 mg/100 g body wt) by gavage once per day, five times a week, over a period of 13 weeks. Methionine treatment significantly affected progression of hepatic tumors induced by DL-ethionine administration. The frequency of rats with hepatocellular carcinomas in the methionine treated group was significantly lower than that in control groups. It therefore appears that methionine treatment resulted in a remission of the malignant process.",
author = "Z. Brada and Altman, {N. H.} and M. Hill and S. Bulba",
year = "1982",
month = "1",
day = "1",
language = "English",
volume = "38",
pages = "157--160",
journal = "Research Communications in Molecular Pathology and Pharmacology",
issn = "0034-5164",
publisher = "PJD Publications Ltd",
number = "1",

}

TY - JOUR

T1 - The effect of methionine on the progression of hepatocellular carcinoma induced by ethionine

AU - Brada, Z.

AU - Altman, N. H.

AU - Hill, M.

AU - Bulba, S.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Female Wistar rats were fed a semisynthetic diet containing 0.3% DL-ethionine for 52 weeks and, most of them bearing hepatocellular carcinomas, were switched to a basal diet for one week and then received 80 mg DL-methionine per rat (cir. 25 mg/100 g body wt) by gavage once per day, five times a week, over a period of 13 weeks. Methionine treatment significantly affected progression of hepatic tumors induced by DL-ethionine administration. The frequency of rats with hepatocellular carcinomas in the methionine treated group was significantly lower than that in control groups. It therefore appears that methionine treatment resulted in a remission of the malignant process.

AB - Female Wistar rats were fed a semisynthetic diet containing 0.3% DL-ethionine for 52 weeks and, most of them bearing hepatocellular carcinomas, were switched to a basal diet for one week and then received 80 mg DL-methionine per rat (cir. 25 mg/100 g body wt) by gavage once per day, five times a week, over a period of 13 weeks. Methionine treatment significantly affected progression of hepatic tumors induced by DL-ethionine administration. The frequency of rats with hepatocellular carcinomas in the methionine treated group was significantly lower than that in control groups. It therefore appears that methionine treatment resulted in a remission of the malignant process.

UR - http://www.scopus.com/inward/record.url?scp=0019920710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019920710&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 157

EP - 160

JO - Research Communications in Molecular Pathology and Pharmacology

JF - Research Communications in Molecular Pathology and Pharmacology

SN - 0034-5164

IS - 1

ER -